XML 36 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
Common Stock
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Common Stock Common Stock
The Company’s common stockholders are entitled to dividends if and when declared by the Company’s Board of Directors, or the Board of Directors. As of December 31, 2023 and 2022, no dividends on the Company’s common stock had been declared by the Board of Directors.
The Company’s common stock has been reserved for the following potential future issuances:
As of December 31,
20232022
Shares underlying outstanding stock options
4,012,903 3,402,574
Shares underlying unvested restricted stock units4,346,785 3,687,888
Shares underlying unvested market-based restricted stock units2,260,764 2,260,764
Shares underlying unvested performance-based restricted stock units412,490 341,713
Shares available for issuance under the 2018 Incentive Award Plan
7,053,406 5,438,296
Shares available for issuance under the 2018 Employee Stock Purchase Plan1,679,635 1,118,311
Shares available for issuance under the 2023 Employment Inducement Incentive Award Plan4,949,988 — 
Total 24,715,97116,249,546
Equity Offering
In May 2023, the Company completed a follow-on underwritten public offering, in which it issued and sold 14,375,000 shares of its common stock at a price of $28.00 per share, and received net proceeds of $381.4 million after deducting underwriting discounts and commissions and other offering costs of $21.1 million. In December 2023, the Company completed a registered direct offering with an investment management firm, in which it issued and sold 3,387,446 shares of its common stock at a price of $26.77 per share, and received net proceeds of $90.6 million.